Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Titel:
Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial
Auteur:
Sax, Paul E Pozniak, Anton Montes, M Luisa Koenig, Ellen DeJesus, Edwin Stellbrink, Hans-Jürgen Antinori, Andrea Workowski, Kimberly Slim, Jihad Reynes, Jacques Garner, Will Custodio, Joseph White, Kirsten SenGupta, Devi Cheng, Andrew Quirk, Erin